Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL17727872

CCc1cccc(C(N)=O)c1N.N

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.46
GABRA1 P14867 2/20 0.43
GABRB2 P47870 2/20 0.43
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CLCN2 P51788 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 2/20 0.40
ABCB11 O95342 1/20 0.40
PTGS1 P23219 1/20 0.40
ADORA1 P30542 1/20 0.40
PTGS2 P35354 1/20 0.40
NR1I2 O75469 1/20 0.39
CHRM2 P08172 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3622854 0.98 PARP1 (0.47) PARP1GABRA1GABRB2MAPTKDM4E
SCHEMBL5685695 0.85 MAPT (0.42) PARP1MAPTKDM4EALDH1A1HPGD
SCHEMBL30742732 0.85 MAPT (0.42) PARP1MAPTKDM4EALDH1A1HPGD
SCHEMBL8943463 0.84 ABCB11 (0.45) MAPTKDM4EALDH1A1HPGDTSHR
SCHEMBL5545298 0.82 PARP1 (0.46) PARP1MAPTKDM4EALDH1A1HPGD
SCHEMBL9058759 0.82 GABRA1 (0.45) GABRA1GABRB2KDM4EALDH1A1CLCN2
SCHEMBL808482 0.82 G6PD (0.57) GABRA1GABRB2KDM4EALDH1A1HPGD
SCHEMBL30762619 0.82 G6PD (0.57) GABRA1GABRB2KDM4EALDH1A1HPGD
SCHEMBL27723424 0.82 KDM4E (0.42) PARP1MAPTKDM4EALDH1A1HPGD
SCHEMBL8558757 0.82 BID (0.45) GABRA1GABRB2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116178266-A Cyano pyrazolone heterobifunctional reagent and application thereof in construction of sugar chip 西北大学 2023-05-30 CN disclosed
CN-107796889-B Method for derivatization and separation analysis of amino pyrazolone iso-bifunctional reagent for reducing sugar chain and glycoprotein O-sugar chain 西北大学 2020-04-10 CN disclosed
US-10413588-B2 Probiotic function of human intelectin WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-09-17 US disclosed
US-10082506-B2 Microbial glycans as a target of human intelectin WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2018-09-25 US disclosed
US-20170136088-A1 PROBIOTIC FUNCTION OF HUMAN INTELECTIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-05-18 US disclosed
US-20160131649-A1 MICROBIAL GLYCANS AS A TARGET OF HUMAN INTELECTIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10082506-B2 Microbial glycans as a target of human intelectin HINT1, DERL1, ENGASE PARP1 2544/4885GABRA1 3686/4885GABRB2 4532/4885
US-20160131649-A1 MICROBIAL GLYCANS AS A TARGET OF HUMAN INTELECTIN HINT1, DERL1, ENGASE PARP1 2544/4885GABRA1 3686/4885GABRB2 4532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.